/
/
/

Aspira Pathlab & Diagnostics Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
---67%
---176%
-9%32%46%
-4%-4%-4%18%

Peer Comparison

Symbol
APOLLOHOSP-A
MAXHEALTH-A
FORTIS-A
ASTERDM-A
NH-A
MEDANTA-A
LALPATHLAB-A
KIMS-A
AGARWALEYE-A
VIJAYA-A
ASPIRA-XT
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
8,675₹126300 Cr60.4540.39207.67₹1942 Cr
992₹96763 Cr66.423.3119.84₹1442 Cr
912.4₹68901 Cr65.753.5320.1₹1042 Cr
790.3₹68592 Cr215.240.316.76₹464 Cr
1,870.95₹38439 Cr47.110.1465.36₹806 Cr
1,486.4₹38149 Cr68.595.9129.85₹556 Cr
1,876₹32259 Cr59.5310.1142.51₹505 Cr
764.95₹32231 Cr157.771.0412.74₹241 Cr
510.2₹16249 Cr109.521.4313.88₹133 Cr
1,495.8₹15511 Cr82.735.1627.53₹173 Cr
96.99₹96 Cr39.90.413.77₹2 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016
₹6 Cr₹7 Cr₹5 Cr₹8 Cr₹5 Cr₹6 Cr₹5 Cr₹6 Cr₹5 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹4 Cr₹3 Cr₹5 Cr₹5 Cr₹3 Cr₹6 Cr₹4 Cr₹4 Cr₹5 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹98 L₹65 L₹61 L₹15 L₹0
₹12 L₹14 L₹13 L₹14 L₹11 L₹13 L₹9 L₹8 L₹9 L₹8 L₹10 L₹14 L₹10 L₹7 L₹12 L₹7 L₹7 L₹4 L₹2 L₹2 L₹2 L₹40,000₹7 L₹7 L₹7 L₹7 L₹7 L₹7 L₹7 L₹8 L₹7 L₹6 L₹5 L₹7 L₹4 L₹6 L₹5 L₹7 L₹10 L₹7 L
₹6 Cr₹7 Cr₹5 Cr₹8 Cr₹5 Cr₹6 Cr₹5 Cr₹6 Cr₹5 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹4 Cr₹3 Cr₹5 Cr₹5 Cr₹4 Cr₹6 Cr₹4 Cr₹4 Cr₹5 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹69 L₹68 L₹26 L₹7 L
₹6 Cr₹7 Cr₹7 Cr₹6 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹4 Cr₹4 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹58 L
₹46 L-₹19 L-₹1 Cr₹2 Cr₹93 L₹1 Cr₹86 L₹1 Cr₹44 L-₹4 L-₹27 L-₹22 L-₹23 L₹21 L₹93 L₹52 L₹24 L₹2 Cr₹1 Cr₹60 L₹2 Cr₹98 L₹84 L₹2 Cr-₹3 L-₹65 L-₹31 L-₹21 L-₹40 L-₹67 L-₹76 L-₹76 L-₹80 L-₹95 L-₹77 L-₹95 L-₹98 L-₹80 L-₹76 L-₹51 L
₹9 L₹10 L₹10 L₹10 L₹9 L₹9 L₹9 L₹8 L₹8 L₹9 L₹9 L₹10 L₹10 L₹10 L₹10 L₹11 L₹11 L₹15 L₹8 L₹7 L₹7 L₹19 L₹22 L₹25 L₹24 L₹25 L₹28 L₹24 L₹25 L₹26 L₹16 L₹26 L₹28 L₹29 L₹18 L₹20 L₹14 L₹8 L₹13 L₹3 L
-₹4 L-₹69 L-₹2 Cr₹2 Cr₹47 L₹72 L₹38 L₹99 L-₹2 L-₹50 L-₹74 L-₹71 L-₹72 L-₹26 L₹44 L₹2 L-₹28 L₹1 Cr₹87 L₹15 L₹2 Cr₹43 L₹26 L₹1 Cr-₹63 L-₹1 Cr-₹1 Cr-₹86 L-₹1 Cr-₹1 Cr-₹1 Cr-₹1 Cr-₹1 Cr-₹1 Cr-₹1 Cr-₹1 Cr-₹1 Cr-₹1 Cr-₹93 L-₹54 L
-₹4 L-₹69 L-₹2 Cr₹2 Cr₹47 L₹72 L₹38 L₹99 L-₹2 L-₹50 L-₹74 L-₹71 L-₹72 L-₹26 L₹44 L₹2 L-₹28 L₹1 Cr₹87 L₹15 L₹2 Cr₹43 L₹26 L₹1 Cr-₹63 L-₹1 Cr-₹1 Cr-₹86 L-₹1 Cr-₹1 Cr-₹1 Cr-₹1 Cr-₹1 Cr-₹1 Cr-₹1 Cr-₹1 Cr-₹1 Cr-₹1 Cr-₹93 L-₹54 L

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Unsecured Loans
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024
₹10 Cr₹10 Cr
₹2 Cr-₹15 L
₹2 Cr-₹15 L
₹12 Cr₹10 Cr
₹1 Cr₹1 Cr
₹1 Cr₹1 Cr
₹55 L₹41 L
₹3 Cr₹2 Cr
₹74 L₹73 L
₹2 Cr₹1 Cr
₹5 L₹3 L
₹2 Cr₹2 Cr
₹17 Cr₹15 Cr
₹1 Cr₹1 Cr
₹1 Cr₹1 Cr
₹18 Cr₹17 Cr
₹12 Cr₹10 Cr
₹7 Cr₹7 Cr
₹8 L₹0
₹8 L₹0
₹4 Cr₹4 Cr
₹2 Cr₹0
₹12 Cr₹10 Cr
₹51 L₹45 L
₹2 Cr₹2 Cr
₹2 Cr₹1 Cr
₹8 L₹6 L
₹27 L₹22 L
₹5 Cr₹4 Cr
₹3 Cr₹2 Cr
₹17 Cr₹15 Cr
₹12₹10
₹12₹10

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024
₹2 Cr-₹3 Cr
₹2 Cr₹2 Cr
-₹2 Cr₹2 Cr
₹2 Cr₹1 Cr
₹2 Cr₹1 Cr
₹12 L₹14 L
-₹99 L-₹95 L
₹95 L₹24 L
₹80 L₹57 L
₹2 Cr₹80 L

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)93.00
Volume (₹)250.00
High (₹)96.99
Upper Circuit97.65
Low (₹)93.00
Lower Circuit88.35
Prev Close93.00
52W High (₹)135.88
Price96.99
52W Low (₹)49.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)95.72 Cr
Div. Yield (%)0.00
PE Ratio39.90
Debt to Equity0.10
Price to Book7.21
Book Value11.82
EPS (TTM)2.33
Face Value10.00
ROE (%)18.13

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
APOLLOHOSP-ANSE
MAXHEALTH-ANSE
FORTIS-ANSE
ASTERDM-ANSE
NH-ANSE
MEDANTA-ANSE
LALPATHLAB-ANSE
KIMS-ANSE
AGARWALEYE-ANSE
VIJAYA-ANSE
ASPIRA-XTNSE
LTP
1W Low
1W High
Market cap (₹)
8668.8-176.9 (-2.00%)
8640.15
8900.90
1,26,300Cr
994.75-18.3 (-1.81%)
985.30
1025
96,763Cr
909.8-20.2 (-2.17%)
893.30
928.80
68,901Cr
784.75+39.6 (5.31%)
745.55
791.55
68,592Cr
1880-51.65 (-2.67%)
1876.80
1949.20
38,439Cr
1473.55+3.05 (0.21%)
1411
1500
38,149Cr
1877-53.7 (-2.78%)
1854.40
1961.20
32,259Cr
767.45-2.35 (-0.31%)
748.30
778.15
32,231Cr
510.5+2.8 (0.55%)
502.60
524.70
16,249Cr
1499.6+47.8 (3.29%)
1451.85
1529.65
15,511Cr
96.99+5.49 (6.00%)
86.50
96.99
96Cr

Aspira Pathlab & Diagnostics Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹92.9Lakh; with other income of ₹10.8Lakh, profit before interest and tax came to ₹56.4Lakh. Interest expense was ₹9.4Lakh; PBT before exceptional items stood at ₹47Lakh. Basis: consolidated annual results.

Aspira Pathlab & Diagnostics Ltd Quaterly Results Key Takeaways

Aspira Pathlab & Diagnostics Ltd reported ₹5.25Cr total income from operations in Jun 2025, softer than ₹5.78Cr in Mar 2025 but higher than ₹4.64Cr in Jun 2024. Operating profit (before other income, interest and exceptional items) was ₹92.9Lakh; with other income of ₹10.8Lakh, profit before interest and tax came to ₹56.4Lakh. Interest expense was ₹9.4Lakh, taking profit before tax to ₹47Lakh. After tax of ₹0 cr, profit after tax stood at ₹47Lakh (vs ₹72.3Lakh in Mar 2025 and ₹-₹1.6Lakh in Jun 2024).